Microwaves are a common appliance in every household now. You will see it in kitchens of not just houses, but offices, cafeterias, and co working space. However, there are studies that show that heating food in a microwave could be a health concern. While it does come handy, there are questions about harmful radiation and nutrient loss and heating safety that still linger.
Some research suggests that microwaving may cause nutritional loss, particularly in vegetables. For example, studies have shown that microwaving broccoli with water diminishes its flavonoid content, which are anti-inflammatory compounds. However, experts note that cooking method and duration have a significant influence on nutrient retention.
Surprisingly, several studies indicate that microwaving preserves more nutrients than traditional cooking methods. A study comparing microwaved versus oven-cooked ready meals found that the microwaved version contained somewhat more vitamin C. Another study discovered that microwaving some vegetables, such as broccoli and green beans, may retain more beneficial compounds than boiling.
Ultimately, the nutrient loss really vary on the type of food which is being heated and how it is being cooked. Experts also recommend using minimal water and shorter cooking times to maximize the nutrient retention.
Plastic containers and heating food in it, has always been a topic of debate. While containers do come with microwave-safe stamps, is it really safe to heat them with food?
According to research, when certain plastics are subjected to heat, they produce compounds such as phthalates and bisphenol A (BPA). These substances have been associated to hormonal disturbance, metabolic problems, and perhaps reproductive concerns.
A study also took in account over 400 plastic food containers that were microwave-safe and found that most of them leaked hormone-disrupting chemicals. These are phthalates, warn experts, which are commonly used in food packaging and can interfere with body's hormonal balance, and increase risk of diabetes or even high blood pressure.
Additionally, BPA exposure has been associated with fertility issues and immune system disruptions.
To minimize this risk, experts recommend using glass or ceramic container when microwaving foods. If you must use a plastic container, make sure the container is not damaged or old, as they are more prone to leach harmful chemicals.
Concerns about microwave radiation have been largely debunked by decades of research. Microwaves use non-ionizing radiation, which does not have enough energy to damage DNA or cause cancer. The electromagnetic waves used in microwaves are similar to those from radios and light bulbs.
Experts emphasize that microwave ovens are designed to contain radiation, preventing exposure. As long as the microwave is in good condition and the door seals properly, there is no significant health risk from microwave radiation.
Microwaving food could sometimes also lead to uneven cooking and it can create some risks to food safety. Thus, experts advertise to use microwave only to reheat the food and not to actually cook raw food. For safe reheating, food should reach at least 82°C (176°F) throughout to kill bacteria.
Credit: iStock
A recent study has found proof that an autoimmune reaction is triggering certain neurological symptoms seen in some long COVID patients. The study, conducted in healthy mice, found that the mice exhibited symptoms mirroring those of affected patients to some extent.
While it has been a long time since the end of the COVID pandemic, its effects continue to linger even today. Several patients who contracted COVID continue to suffer.
A US NIH-funded research group, directed by Drs. Akiko Iwasaki and Tamas L. Horvath of the Yale University School of Medicine and Dr. David Putrino of the Icahn School of Medicine at Mount Sinai recently found that autoantibodies could be triggering these neurological symptoms in some long COVID patients.
Antibodies, in a healthy person, help fight infections. In patients with autoimmune diseases, these antibodies target the body’s own tissues. They are called autoantibodies.
The study also discovered that patients who had these autoantibodies are more likely to experience similar symptoms. For example, people with autoantibodies are more likely to face symptoms like loss of taste and smell. They are also more likely to experience nausea and joint pain.
The researchers conducted the study by transferring purified antibodies from long COVID patients into healthy mice. It was discovered that the mice developed the following changes that resembled the donors' symptoms:
The recent breakthrough in long COVID research has brought the healthcare industry one step closer to personalizing care for those affected.
Dr. Putrino says, “Our study now shows that if you are in a subgroup of Long COVID patients who have autoantibodies circulating in your body, this is a quantifiable sign that you may be a good candidate for these drugs.”
The study finds that cardiovascular diseases were more common among long COVID patients. It concluded that 11.9% of those with long COVID have CVD compared to 6.8% without this condition.
Specifically, it further revealed that long COVID was associated with a higher risk of chest pain and heart attack, but not coronary heart disease and stroke.
Credit: iStock
There is a growing belief that ‘sugar feeds cancer.’ Because of this, many people think that stopping sugar and carbohydrates completely can starve cancer cells and help defeat the disease. However, the trend may have side effects. This half-truth is becoming dangerous for many patients. This trend is making it even more difficult for patients to cope with the side effects of chemotherapy.
This fact is not entirely unscientific, but it is incomplete. In 1924, the German scientist Otto Warburg found that cancer cells consume more glucose than normal cells. This phenomenon is known as the Warburg Effect.
This finding has subsequently been validated in numerous studies. This is also the reason why cancer cells appear clearly in PET-CT scans. They absorb glucose-like substances more aggressively than normal cells. But this does not mean cancer can be “starved” by reducing sugar in food.
Glucose is an essential fuel for the human body. The brain, heart, red blood cells, and immune system all depend on it.
If a person completely stops eating carbohydrates, the body starts producing glucose on its own. It breaks down muscles and proteins to make energy. This process is known as gluconeogenesis. This means the cancer cells still receive fuel, but the patient’s body becomes weaker day by day. This condition is described as ‘cancer cachexia.’
In this condition, body weight and muscle mass reduce rapidly. Such patients often cannot tolerate chemotherapy and surgery properly. In some cases, their protein levels and white blood cell counts had dropped too much.
As a result, doctors had to delay treatment, reduce medicine doses, or even stop some treatment cycles. Irony is painful. In trying to starve cancer, patients sometimes end up weakening their own bodies so much that proper treatment becomes difficult.
In my clinic, I see it almost every week. In such a case, a cancer patient walks in visibly frail. She almost had lost several kilograms over the past month. When I asked about her diet, her IT professional son said that she has cut out sugar entirely. The reason behind this was the same reel-based knowledge about sugar and cancer cells. His son strictly follows this half-truth. Due to her weakness, we had to push back her treatment for a few weeks.
We simply suggest avoiding foods that rapidly increase blood sugar levels. These include refined sugar, sweets, soft drinks, maida, and highly processed foods. We advise cancer patients to eat complex carbohydrates, whole grains, pulses, vegetables, healthy fats, and enough protein. The best way is not to cut sugar entirely, but to lower the glycemic load.
Some animal studies have shown the benefits of fasting during cancer treatment. However, there is still not enough evidence in humans. For patients who are already weak or losing weight rapidly, long fasting can become harmful.
Cancer cells use more glucose, but starving the body cannot stop cancer. If you want to help your body, then avoid refined sugar and junk food, but continue eating balanced meals. Because sufficient protein and calories are extremely important. Practising long fasting without medical advice is harmful. The goal should be to keep the body stable and strong, not weak.
The purpose of cancer nutrition is to nourish the patient, not to starve them. Proper nutrition helps the body tolerate treatment and fight disease more effectively. What is needed is to reduce the intake of refined sugar and foods with a high glycemic index, not to declare every carbohydrate an enemy. After all, one cannot win the battle against disease by weakening the body.
Credits: iStock
A new oral weight-loss drug is showing promising results for people living with obesity or who are overweight. In a phase II clinical trial published in Nature Medicine, participants taking the experimental medication aleniglipron lost up to 12% of their body weight over 36 weeks.
The study included contributions from Robert Kushner, MD, professor emeritus of medicine at Northwestern University and a longtime expert in obesity treatment.
Aleniglipron belongs to the GLP-1 family of drugs, the same class as popular medications such as Ozempic and Wegovy. These treatments help people lose weight by mimicking a natural hormone that reduces appetite, increases feelings of fullness, and helps regulate blood sugar levels.
What makes aleniglipron different is that it comes in pill form. Most currently available GLP-1 medications require injections and often need special storage, which can make them less convenient and more difficult for some patients to access.
Researchers believe an oral option could make treatment easier for many people. Because aleniglipron is a small-molecule drug—meaning it is chemically manufactured rather than peptide-based—it can be produced more efficiently and potentially at a lower cost.
“Aleniglipron is different because it’s a small molecule that can be taken with or without food,” Kushner said. “Most medicines people take every day, from aspirin to blood pressure drugs, are small molecules. That also creates opportunities to combine it with other treatments in the future.”
If further studies confirm its safety and effectiveness, aleniglipron could offer a more convenient alternative to injectable GLP-1 medications and help expand access to obesity treatment.
Dr Shubham Vatsya explains that it took 20 years of research for scientists to come up with these medicines. This drug underwent proper lengthy trials, and have been approved by the US Food and Drug Administration (FDA), "which is not obtained by giving any bribe".
He also noted that when a person is not able to lose weight, Ozempic and drugs alike give a "head start" to them, along with a hope.
Talking about side effects, he says that every drug has its side effects, this is where a doctor's role comes in.
"Now, the person who is not able to lose weight, if you tell him 'you hit 100 kg bench press', he will break his shoulder. He needs a kickstart somewhere. This is what weight loss drugs allow," he says.
He also points out that the scientists who made GLP-1 agonists got a Nobel Prize, which "cannot be a scam". This is what makes weight loss drugs truly different.
Also Read: Raising Sons Linked to Faster Cognitive Decline in Later Life, Study Find
GLP-1 Drugs stand for Glucagon-like peptide 1, a naturally occurring hormones that helps regulate blood sugar and appetite after eating. It was first identified almost 50 years ago and scientists have since uncovered its role in type 2 diabetes.
© 2024 Bennett, Coleman & Company Limited